SCHEMBL10282157

SCHEMBL10282157

Cc1cc(N)nn1C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 1/20 0.43
SIGMAR1 Q99720 1/20 0.40
PDE7A Q13946 4/20 0.38
FLT3 P36888 1/20 0.38
MAPT P10636 2/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX15 P16050 2/20 0.37
ESR1 P03372 1/20 0.36
GAA P10253 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CDK9 P50750 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK2 Q92630 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31052495 0.98 HPGD (0.43) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL3364096 0.81 ALDH1A1 (0.49) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL31462462 0.81 ALDH1A1 (0.49) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL31018653 0.80 TEAD1 (0.37) ALOX15
SCHEMBL23748795 0.79 KDM4E (0.46) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL19300056 0.78 ALDH1A1 (0.43) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL17356152 0.76 ALDH1A1 (0.42) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL21191294 0.76 ALDH1A1 (0.42) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL18164031 0.76 SIGMAR1 (0.41) HPGDALDH1A1KDM4EHSD17B10SIGMAR1
SCHEMBL31018548 0.75 MAP3K12 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287161-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 EP disclosed